Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott D Solomon

Showing results (281-290 of 1,211) with videos related to

Pageof 122
Sort By:
The American Journal of Cardiology|June 29, 2004
Effect of antecedent systemic hypertension on subsequent left ventricular dilation after acute myocardial infarction (from the Survival and Ventricular Enlargement trial)Satish Kenchaiah, Marc A Pfeffer, Martin St John Sutton, et al.
Circulation. Cardiovascular Imaging|September 15, 2016
Smoking and Cardiac Structure and Function in the Elderly: The ARIC Study (Atherosclerosis Risk in Communities)Wilson Nadruz, Brian Claggett, Alexandra Gonçalves, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|February 7, 2012
Mechanisms and predictors of mitral regurgitation after high-risk myocardial infarctionAlessandra Meris, Maria Amigoni, Anil Verma, et al.
Journal of the American College of Cardiology|October 11, 2011
Cardiac resynchronization therapy reduces left atrial volume and the risk of atrial tachyarrhythmias in MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy)Andrew Brenyo, Mark S Link, Alon Barsheshet, et al.
European Journal of Heart Failure|April 3, 2014
Independence of the blood pressure lowering effect and efficacy of the angiotensin receptor neprilysin inhibitor, LCZ696, in patients with heart failure with preserved ejection fraction: an analysis of the PARAMOUNT trialPardeep S Jhund, Brian Claggett, Milton Packer, et al.
JAMA Cardiology|March 17, 2021
Association of Left Ventricular Systolic Function With Incident Heart Failure in Late LifeAnne Marie Reimer Jensen, Rani Zierath, Brian Claggett, et al.
European Journal of Heart Failure|January 23, 2025
Canagliflozin reduces oral loop diuretic intensification in patients with type 2 diabetes: A participant-level pooled analysis of the CANVAS and CREDENCE trialsSafia Chatur, Muthiah Vaduganathan, Robert A Fletcher, et al.
European Journal of Heart Failure|November 2, 2010
Predictors and prognostic impact of recurrent myocardial infarction in patients with left ventricular dysfunction, heart failure, or both following a first myocardial infarctionJens Jakob Thune, James E Signorovitch, Lars Kober, et al.
Heart Rhythm|July 23, 2013
Response of right ventricular size to treatment with cardiac resynchronization therapy and the risk of ventricular tachyarrhythmias in MADIT-CRTColin L Doyle, David T Huang, Arthur J Moss, et al.
JACC. Heart Failure|November 15, 2020
Cardiovascular and Renal Outcomes of Mineralocorticoid Receptor Antagonist Use in PARAGON-HFKarola S Jering, Faiez Zannad, Brian Claggett, et al.
Pageof 122

Showing results (281-290 of 1,211) with videos related to

Sort By:
Pageof 122
The American Journal of Cardiology|June 29, 2004
Effect of antecedent systemic hypertension on subsequent left ventricular dilation after acute myocardial infarction (from the Survival and Ventricular Enlargement trial)Satish Kenchaiah, Marc A Pfeffer, Martin St John Sutton, et al.
Circulation. Cardiovascular Imaging|September 15, 2016
Smoking and Cardiac Structure and Function in the Elderly: The ARIC Study (Atherosclerosis Risk in Communities)Wilson Nadruz, Brian Claggett, Alexandra Gonçalves, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|February 7, 2012
Mechanisms and predictors of mitral regurgitation after high-risk myocardial infarctionAlessandra Meris, Maria Amigoni, Anil Verma, et al.
Journal of the American College of Cardiology|October 11, 2011
Cardiac resynchronization therapy reduces left atrial volume and the risk of atrial tachyarrhythmias in MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy)Andrew Brenyo, Mark S Link, Alon Barsheshet, et al.
European Journal of Heart Failure|April 3, 2014
Independence of the blood pressure lowering effect and efficacy of the angiotensin receptor neprilysin inhibitor, LCZ696, in patients with heart failure with preserved ejection fraction: an analysis of the PARAMOUNT trialPardeep S Jhund, Brian Claggett, Milton Packer, et al.
JAMA Cardiology|March 17, 2021
Association of Left Ventricular Systolic Function With Incident Heart Failure in Late LifeAnne Marie Reimer Jensen, Rani Zierath, Brian Claggett, et al.
European Journal of Heart Failure|January 23, 2025
Canagliflozin reduces oral loop diuretic intensification in patients with type 2 diabetes: A participant-level pooled analysis of the CANVAS and CREDENCE trialsSafia Chatur, Muthiah Vaduganathan, Robert A Fletcher, et al.
European Journal of Heart Failure|November 2, 2010
Predictors and prognostic impact of recurrent myocardial infarction in patients with left ventricular dysfunction, heart failure, or both following a first myocardial infarctionJens Jakob Thune, James E Signorovitch, Lars Kober, et al.
Heart Rhythm|July 23, 2013
Response of right ventricular size to treatment with cardiac resynchronization therapy and the risk of ventricular tachyarrhythmias in MADIT-CRTColin L Doyle, David T Huang, Arthur J Moss, et al.
JACC. Heart Failure|November 15, 2020
Cardiovascular and Renal Outcomes of Mineralocorticoid Receptor Antagonist Use in PARAGON-HFKarola S Jering, Faiez Zannad, Brian Claggett, et al.
Pageof 122